What is LOPJLB’s current signal on DMRA?

LOPJLB’s latest quantitative signal on Damora Therapeutics, Inc. (DMRA) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is DMRA in?

Damora Therapeutics, Inc. (DMRA) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Damora Therapeutics, Inc. (DMRA) do?

Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America. The companyâs lead product includes DMR-001, a investigational monoclonal antibody therapy that targets mutations in CALR, for the treatment of essential thrombocythemia; and DMR-002 and DMR-003, both anti-mutCALR-based therapies, with the intent …

Where is Damora Therapeutics, Inc. based / listed?

Damora Therapeutics, Inc. is based in US, listed on NASDAQ.

Damora Therapeutics, Inc. (DMRA)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$20.56+1.58%Close

SELLCRISIS · day 18

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $1.3B
Beta: 1.44
P/E (TTM): -0.16

Short % float: 11.48%
Days to cover: 8.6
SI change: +14.6%

1W: +1.63%
1M: -21.74%

vs SPY 1W: +0.07%
vs SPY 1M: -23.50%

Industry peers

FMP comparable companies · ranked by market cap

GMABBUYGenmab A/S$23.2BBULLQ 21$37.80-1.64%
INCYSELLIncyte Corporation$22.9BBEARQ 13$112.73-0.61%
IRONSELLDisc Medicine, Inc.$2.4BCRISISQ 1$61.65-0.67%
QURESELLuniQure N.V.$1.6BCRISISQ 17$23.06-2.59%
COAGSELLHemab Therapeutics Holdings, Inc. Common Stock$1.3BQ -6$28.37+7.63%
RIGLBUYRigel Pharmaceuticals, Inc.$853MBULLQ 9$46.11+1.52%
GERNSELLGeron Corporation$776MRECOVERYQ 11$1.21+1.67%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news